Home / Albendazole / Austria
AT ATC P02CA03 · updated 2 Nov 2026
Albendazole shortage in Austria
Is there an Albendazole shortage in Austria?
Yes. As of 2 Nov 2026, 1 Albendazole product is reported short in Austria, the first since 13 Jun 2025. The company estimate for the return is 31 Mar 2028. Main reason: active ingredient shortage.
Also short in France, Italy, Spain, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Eskazole 400 mg - Tabletten, 12 Stück | Glaxosmithkline Pharma GmbH | 13 Jun 2025 | 31 Mar 2028 | Active ingredient shortage Verknappung des Wirkstoffes |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).